Czechia· CZ-0271712
HYFTOR
A sirolimus product containing sirolimus, registered in Czechia by Plusultra pharma GmbH, Düsseldorf. The same ATC class is registered in 6 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Sirolimus is registered in 6 of 19 countries.
Countries holding a registration under ATC L01EG04 (sirolimus), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 4 of them publish a price we can compare per daily dose
Sirolimus · ATC L01EG04
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Japan
- Norwayprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- SIROLIMUS
- Manufacturer
- Plusultra pharma GmbH, Düsseldorf
- Country
- Czechia (CZ)
- ATC code
- L01EG04
- ATC class
- Sirolimus
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
737 interactions on record for sirolimus.
Graded by severity as the source publishes them — 162 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sirolimus · interactions on record
737 records
- 162 severe
- 441 moderate
- 8 minor
- 126 info
Most severe, free to view
- ClotrimazoleA01AB18severe
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sirolimus in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumHyftor 2 mg/gPlusultra Pharma
- United StatesFYARROAadi Bioscience, Inc.
- United KingdomHyftor 2mg/g gelPlusultra Pharma UK Ltd
- SwitzerlandRapamune 0.5 mg, überzogene TablettenPfizer AG
- IrelandHYFTOR 2 mg/g GelPlusultra Pharma GmbH
- FinlandHyftorPlusultra Pharma GmbH
- PolandHyftorPlusultra pharma GmbH
- SwedenHyftor 2 mg/g GelPlusultra pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Sirolimus Panacea Biotec
- Iceland · Hyftor, Rapamune
- Liechtenstein · Hyftor, Rapamune
- Norway · Hyftor, Rapamune
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1fcf9bc4-da6c-48a2-bb80-df41ff942ca5 GET /v1/drugs/1fcf9bc4-da6c-48a2-bb80-df41ff942ca5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "GEL",
"source": "sukl",
"strength": "2MG/G",
"pack_size": "1X10G",
"substance": "SIROLIMUS",
"cz_kod_sukl": "0271712",
"product_type": null,
"substance_codes": "13705",
"registration_state": "R",
"registration_number": "EU/1/23/1723/001"
}See everything about sirolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.